Paroxysmal atrial fibrillation
MONDO:1030011An atrial fibrillation disorder characterized by intermittent atrial fibrillation that lasts less than seven days from onset.
Also known as: paroxymsal AFib, paroxysmal AF
327 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New heart procedure tested for AFib control
Disease control OngoingThis study looks at how safe and effective a new treatment called FARAPULSE pulsed field ablation is for people with a type of irregular heartbeat called paroxysmal atrial fibrillation. About 228 participants will be followed for up to 12 months to see if the procedure stops the …
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New catheter combo aims to keep AFib in check longer
Disease control OngoingThis study looks at how well a special catheter (THERMOCOOL SMARTTOUCH SF) and software (Ablation Index) work to treat paroxysmal atrial fibrillation, a type of irregular heartbeat. Researchers will track 150 adults who get this procedure to see if they stay free of heart rhythm …
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New antibiotic pouch aims to stop infections in heart device patients
Disease control OngoingThis study is tracking 100 adults who receive an EluPro antibiotic-eluting envelope during implantation of a heart device (like a pacemaker). The envelope slowly releases antibiotics to prevent infection. Researchers are monitoring complication rates in real-world use to see how …
Sponsor: Elutia Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New weekly shot could help severely obese heart patients shed pounds
Disease control OngoingThis Phase 3 study tests a weekly injection called retatrutide in about 1,946 people with severe obesity (BMI ≥35) and established heart disease. The goal is to see if it helps with weight loss and improves heart-related health measures over 113 weeks compared to a placebo. Parti…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a weekly shot slash heart attack risk? major trial underway
Disease control OngoingThis study tests whether a weekly injection of CagriSema (a combination of two drugs) can reduce the risk of heart attacks, strokes, and other heart-related events in people with established cardiovascular disease. About 7,100 participants will receive either CagriSema or a place…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Zap away heart flutters: new device trial offers hope for AF patients
Disease control OngoingThis study tests a new device that uses special electrical pulses to treat paroxysmal atrial fibrillation, a condition where the heart beats irregularly. About 150 adults aged 18-75 who have not responded well to medication will receive the treatment. The goal is to see if the de…
Phase: NA • Sponsor: Shanghai Shangyang Medical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Can removing blood before heart surgery cut transfusions? large trial aims to find out.
Disease control OngoingThis study tests a technique called acute normovolemic hemodilution (ANH) in 2000 high-risk heart surgery patients. Before the heart-lung machine is used, doctors remove some blood and replace it with fluids. The goal is to see if this reduces the number of patients who need a bl…
Phase: NA • Sponsor: Università Vita-Salute San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New heart procedure could tame irregular heartbeat
Disease control OngoingThis study tests a new device system that uses pulsed electric fields to treat atrial fibrillation, a common heart rhythm problem. About 300 people with symptomatic, recurrent atrial fibrillation will receive the procedure. The goal is to see if it safely and effectively restores…
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug aims to cut heart attacks in High-Risk patients
Disease control OngoingThis phase 3 trial tests whether a monthly injection of pelacarsen can reduce major heart problems like heart attacks and strokes in people with high levels of Lp(a), a genetic risk factor. Over 8,000 participants with existing heart disease are being followed for several years. …
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New ablation strategy aims to keep hearts in rhythm longer
Disease control OngoingThis study compares two catheter ablation techniques for atrial fibrillation (AF), a condition where the heart beats irregularly. One method uses a standard approach with a drug called adenosine to find missed spots, while the other adds an extra ring of ablation without the drug…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New heart lead under watch: 5-Year safety check begins
Disease control ENROLLING_BY_INVITATIONThis study follows 2000 people who have or will get the OmniaSecure defibrillation lead, a wire that helps control dangerous heart rhythms. Researchers will track how often the lead causes problems over 5 years. The goal is to make sure the lead is safe and works as expected in e…
Sponsor: Medtronic • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New heart procedure aims to stop persistent AFib in its tracks
Disease control OngoingThis study looks at two ways to treat a type of irregular heartbeat called non-paroxysmal atrial fibrillation (AFib) that doesn't go away on its own. Both methods use a new technique called pulsed-field ablation to destroy tiny areas of heart tissue causing the problem. One group…
Phase: NA • Sponsor: Xu Liu • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New heart procedure aims to zap AFib safely
Disease control OngoingThis study tests a device called the Farapulse system, which uses electrical pulses to treat atrial fibrillation (AFib), a common heart rhythm problem. Researchers will enroll 275 adults with AFib who are already scheduled for a catheter ablation procedure. The goal is to see if …
Phase: PHASE4 • Sponsor: Vivek Reddy • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can tighter blood pressure control save hearts in diabetes? massive trial aims to find out
Disease control OngoingThis large study is testing whether a lower blood pressure target can reduce major heart problems like heart attacks, strokes, and heart failure in people with type 2 diabetes. About 9,500 participants with high blood pressure and high cardiovascular risk are being randomly assig…
Phase: NA • Sponsor: Hospital Israelita Albert Einstein • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New heart procedure could be safer and just as effective for AFib
Disease control OngoingThis study compares two ways to treat a heart condition called atrial fibrillation (AFib) that causes an irregular heartbeat. The standard method uses freezing (cryoballoon), while the newer method uses electrical pulses (pulsed field ablation). The goal is to see if the new meth…
Phase: PHASE4 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Blood test may help Fine-Tune heart drug dosing
Disease control ENROLLING_BY_INVITATIONThis study tests whether measuring amiodarone levels in the blood helps doctors choose the right dose for people with paroxysmal atrial fibrillation (a type of irregular heartbeat). About 80 adults will receive different daily doses (100, 200, or 400 mg) and be monitored for thre…
Phase: PHASE4 • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Heart rhythm showdown: ablation may beat drugs for ventricular tachycardia
Disease control OngoingThis trial tests whether a procedure called catheter ablation works better than anti-arrhythmic drugs for people with structural heart disease who have had a dangerous fast heart rhythm (ventricular tachycardia). About 162 participants will be randomly assigned to either ablation…
Phase: NA • Sponsor: Western Sydney Local Health District • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New heart device aims to zap away irregular rhythm
Disease control OngoingThis study tests a new device called the Globe Pulsed Field System to treat people with atrial fibrillation (AF), a common heart rhythm problem. The device uses electrical pulses to destroy small areas of heart tissue causing the irregular rhythm. About 549 participants will be f…
Phase: NA • Sponsor: Kardium Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New mapping tech aims to sharpen heart ablation for AFib
Disease control TerminatedThis pilot study was designed to test a new, more targeted way to perform ablation for atrial fibrillation (AFib). Instead of burning a wide area around the pulmonary veins, doctors would use special mapping technology to precisely target the heart muscle sleeves causing the abno…
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Sleep apnea device may keep heart rhythm in check
Disease control OngoingThis study looks at whether using a CPAP machine at night can reduce the chance of atrial fibrillation (an irregular heartbeat) returning in people who have both sleep apnea and a history of AF. Researchers will follow 91 adults for 12 months, tracking how often they use CPAP and…
Sponsor: Medical University of Sofia • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Gut bacteria capsules may shield heart surgery patients from organ damage
Disease control ENROLLING_BY_INVITATIONThis study tests whether giving patients capsules containing gut bacteria (called Probacine) before and after heart surgery can reduce gut injury and organ failure. Researchers will enroll 500 adults undergoing cardiovascular surgery. The goal is to see if changing the gut microb…
Phase: NA • Sponsor: Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New balloon zaps away AFib without heat
Disease control OngoingThis study tests a new balloon catheter that uses pulsed electric fields instead of heat to treat atrial fibrillation (AFib), a common heart rhythm problem. About 35 adults with short-lasting AFib will receive the procedure. The goal is to see if the balloon safely and effectivel…
Phase: NA • Sponsor: The Third People's Hospital of Chengdu • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New study examines real-world use of heart ablation device for AFib patients
Disease control OngoingThis study tracks 344 adults with paroxysmal atrial fibrillation (a type of irregular heartbeat) who are having their first catheter ablation procedure using a specific device. The goal is to see how well the procedure works and how safe it is in everyday medical practice. Resear…
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Heart monitor after ablation may cut AF time
Disease control OngoingThis study tests whether using an implantable heart monitor (or a wearable patch) to detect atrial fibrillation early after catheter ablation can reduce the total time spent in AF. About 120 people with paroxysmal or persistent AF will be monitored for 15 months. The goal is to s…
Phase: NA • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Freezing heart tissue: new balloon trial for AFib patients
Disease control OngoingThis trial tests a new device called the Synaptic Cryoablation System, which uses a balloon to freeze small areas of the heart and correct irregular heartbeats in people with paroxysmal atrial fibrillation. 128 participants will receive the treatment and be followed for 12 months…
Phase: NA • Sponsor: Synaptic Medical Corporation • Aim: Disease control
Last updated Jun 26, 2026 16:53 UTC
-
Leg movement may predict heart risk in seniors
Diagnosis OngoingThis study explores whether a simple, non-invasive leg movement test can measure blood vessel health in older adults. Researchers will use ultrasound to track blood flow changes after a passive leg movement, comparing young healthy people and older patients undergoing heart tests…
Sponsor: VA Office of Research and Development • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Massive study tests if daily pills can ward off cancer and heart attacks
Prevention OngoingThis large study tested whether taking daily vitamin D3 and omega-3 (fish oil) supplements can lower the risk of developing cancer, heart disease, or stroke. Over 25,000 healthy older adults (men 50+, women 55+) took the supplements or placebos for about 5 years. The goal is to s…
Phase: PHASE3 • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 07:56 UTC
-
Heart rehab gets personal: new program targets Women's sexual Well-Being
Symptom relief OngoingThis study tests a nurse-led education program designed to help women in cardiac rehab address sexual concerns after a heart event. Sixty-six women will be randomly assigned to either the program or usual care. The goal is to see if the program improves sexual function, mood, and…
Phase: NA • Sponsor: Hospital Universitario Virgen Macarena • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Can a blood flow cuff boost heart rehab?
Symptom relief OngoingThis study tests whether adding blood flow restriction (BFR) to standard resistance training helps heart rehab patients get stronger and healthier. Twenty adults with stable heart disease will do exercises with and without a special cuff that limits blood flow to the arms and leg…
Phase: NA • Sponsor: University of Valencia • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Could a simple nerve block cut opioid use after heart surgery?
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a nerve block given before heart surgery can reduce pain and the need for opioid painkillers afterward. About 150 adults having heart surgery will receive either a long-acting or standard form of the numbing drug bupivacaine via ultrasound-guided injectio…
Phase: PHASE2, PHASE3 • Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Heart rehab gets a meaning boost: new study tests existential support
Symptom relief ENROLLING_BY_INVITATIONThis study tests a short program that helps heart patients and their families explore what gives life meaning during cardiac rehab. About 80 people in Denmark will try one of three formats: one-on-one, with a relative, or in a group. The goal is to see if this approach can reduce…
Phase: NA • Sponsor: University of Southern Denmark • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Heart Patients' hidden danger: risky drug mixes under the microscope
Knowledge-focused OngoingThis study tracks 120 adults with heart disease and at least two other long-term illnesses to see how often dangerous drug interactions happen. Researchers check medications, including over-the-counter and herbal products, and follow participants for a year. The goal is to unders…
Sponsor: National Medical Research Center for Therapy and Preventive Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Heart device DiamondTemp under Real-World watch: will it deliver?
Knowledge-focused OngoingThis registry follows 545 people with arrhythmia who received a heart ablation using the DiamondTemp system. Researchers will track how many stay free of their heart rhythm problem and how many have serious side effects over 12 months. The goal is to see how well the device works…
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Heart patients face bleeding and clot risks after joint surgery – new study investigates
Knowledge-focused OngoingThis study tracks over 1,700 heart patients who had hip or knee replacement surgery. Researchers want to see how often bleeding or blood clots happen in the months after surgery. The goal is to find better ways to prevent these complications.
Sponsor: I.M. Sechenov First Moscow State Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New algorithm aims to predict AF recurrence after ablation
Knowledge-focused OngoingThis study looks at whether a new computer algorithm can predict if atrial fibrillation (an irregular heartbeat) will come back after a common treatment called pulmonary vein isolation. Researchers will review medical records from 300 patients who had this procedure. The goal is …
Sponsor: CathVision ApS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New study aims to make heart ablation faster and safer
Knowledge-focused OngoingThis study looks at two methods for treating atrial fibrillation (an irregular heartbeat) using a special balloon catheter. The goal is to see if using a 3D mapping system (CARTO) makes the procedure faster and safer than using X-ray guidance alone. About 60 adults with paroxysma…
Phase: NA • Sponsor: Maria Cecilia Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
200,000 heart patients enrolled in massive 5-Year fitness tracking study
Knowledge-focused ENROLLING_BY_INVITATIONThis study will observe 200,000 Chinese adults with heart disease to see how their heart and lung function changes over 5 years. Participants will take a special exercise test to measure their fitness. Researchers hope to find better ways to predict future heart problems like hea…
Sponsor: Guangdong Provincial People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Massive heart study aims to unlock secrets of cardiovascular disease
Knowledge-focused OngoingThis study is a large registry that collects medical data and tissue samples from 30,000 people with heart disease and healthy volunteers. Researchers will analyze this information to better understand risk factors, treatments, and outcomes for various heart conditions. The goal …
Sponsor: Intermountain Health Care, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Heart disease study aims to unlock genetic secrets of dilated cardiomyopathy
Knowledge-focused OngoingThis study follows 2000 people with dilated cardiomyopathy (a weakened, enlarged heart) over several years to learn how genetics and heart scarring affect the disease. Participants give blood for genetic testing and have heart MRI scans. The goal is to improve diagnosis and pave …
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
ICU stay throws body clocks out of sync, new study reveals
Knowledge-focused OngoingThis study looks at how being in a hospital intensive care unit (ICU) after heart surgery affects your body's natural sleep-wake cycle. Researchers will track sleep patterns and thinking ability in 15 adults to see if disrupted rhythms slow down recovery. The goal is to understan…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Study on faster recovery after heart procedure pulled before starting
Knowledge-focused TerminatedThis study aimed to see if using a special pad along with a standard closure device could help patients get out of bed sooner after a heart catheterization. It was planned for adults having the procedure through the groin. However, the study was withdrawn before any participants …
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Could cooling the esophagus make heart ablation safer?
Knowledge-focused OngoingThis study looks at whether actively cooling the esophagus during a common heart procedure (ablation for atrial fibrillation) helps improve outcomes and reduce side effects. Researchers will follow 312 adults with symptomatic atrial fibrillation who are already scheduled for abla…
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
New registry aims to uncover hidden risks for pregnant women with heart disease
Knowledge-focused OngoingThis registry follows 75 pregnant women with heart disease to better understand the risks and outcomes for both mother and baby. Researchers will track health data for one year and check vital status at five years. The goal is to fill knowledge gaps and improve future care for th…
Sponsor: Saint Luke's Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
New study aims to predict swallowing trouble after heart surgery
Knowledge-focused OngoingThis study follows 347 heart surgery patients to understand why some develop swallowing problems (dysphagia). Researchers will use special camera tests to watch how patients swallow and look for risk factors. The goal is to create simple tools that doctors can use at the bedside …
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
New mapping technique for AF ablation never tested – study withdrawn
Knowledge-focused TerminatedThis study was designed to see if a new, ultra-sensitive mapping technique could better confirm that cryoballoon ablation successfully isolated the pulmonary veins in patients with paroxysmal atrial fibrillation. The trial was withdrawn before enrolling any participants, so no re…
Sponsor: BayCare Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
10,000 heart scans could unlock secrets of cardiovascular disease
Knowledge-focused OngoingThis study is following 10,000 adults who are having a heart MRI for medical reasons. Researchers want to see if the MRI results can help predict who will have heart problems in the future, like heart attacks or heart failure. The goal is to better understand how MRI scans can gu…
Sponsor: Manchester University NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC